O2M Technologies LLC
Chicago, IL
- UEI
- RLM1GHQF3MM6
- CAGE
- 7TUN7
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2201 W Campbell Park Dr #310, Chicago, IL 60612, USA
- Website
- oxygenimaging.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Advanced imaging methods in pulse EPR - abstract: precise partial oxygen pressure (PO2) measurements can guide… | National Cancer Institute | $1,164,814 | |
| Multifunctional epri instrument to advance therapies in biomedical sciences - abstract: electron paramagnetic… | National Cancer Institute | $400,000 | |
| Methods for fast and efficient oxygen imaging - abstract intermittent or acute/cyclic hypoxia in tumors, with… | National Cancer Institute | $400,000 | |
| Topic 421: building the world's first clinical oxygen imager for efficient cancer treatment | National Cancer Institute | $400,000 | |
| Sbir phase II: enabling technologies for noninvasive oxygen imaging in regenerative medicine | National Science Foundation | $1,883,745 |
About O2M Technologies LLC
O2M Technologies LLC is a small, for-profit corporate entity specializing in advanced oxygen imaging technologies, with a primary focus on developing innovative medical imaging solutions for cancer research and regenerative medicine. Registered in SAM.gov since March 2017, the company has established itself as a technology development firm with expertise in electron paramagnetic resonance (EPR) imaging techniques. Their technological innovations center on creating sophisticated imaging methods that can generate precise three-dimensional partial oxygen pressure (pO2) maps of tissues, which have critical applications in understanding and treating cancer, evaluating tissue engineering processes, and developing advanced medical imaging technologies.
Through federal contract awards, O2M Technologies LLC has demonstrated capability in developing specialized medical imaging technologies, specifically through a Small Business Innovation Research (SBIR) program contract with the National Institutes of Health National Cancer Institute. This $455,000 firm fixed-price contract was awarded in September 2021 and focused on building the world's first clinical oxygen imager for cancer treatment. The contract was set aside for total small business participation and involved developing pulse electron paramagnetic resonance technologies to generate 3D pO2 maps of tissues, providing valuable diagnostic and treatment guidance information for cancer researchers and medical professionals.
O2M Technologies LLC has been particularly successful in securing federal grant awards, predominantly from the National Cancer Institute and National Science Foundation. These grants, totaling over $1.5 million, have supported advanced research in oxygen imaging technologies across multiple projects. Key grant objectives have included developing multifunctional imaging instruments capable of simultaneously acquiring tissue oxygen pressure and pH maps, improving single-point imaging acquisition speeds using advanced hardware and deep learning, and creating enabling technologies for noninvasive oxygen imaging in regenerative medicine. The company has also engaged in collaborative sub-grant work with institutions like Dartmouth College and the University of Denver, demonstrating its ability to partner with academic research organizations to advance medical imaging technologies. Their grant work spans critical areas such as cancer detection, tissue engineering, and developing advanced imaging methods that could potentially transform medical diagnostic and treatment approaches.
Quick answers
What is O2M Technologies LLC's UEI?
O2M Technologies LLC's Unique Entity ID (UEI) in SAM.gov is RLM1GHQF3MM6.
What is O2M Technologies LLC's CAGE code?
O2M Technologies LLC's CAGE code is 7TUN7.
What is O2M Technologies LLC's primary NAICS code?
O2M Technologies LLC's primary NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).
Where is O2M Technologies LLC located?
O2M Technologies LLC's physical address in SAM.gov is 2201 W Campbell Park Dr #310, Chicago, IL 60612, USA.
Is O2M Technologies LLC registered in SAM.gov?
Yes. O2M Technologies LLC's SAM.gov registration is active through September 11, 2027.
What is O2M Technologies LLC's most recent federal award?
O2M Technologies LLC's most recent federal grant award is Advanced imaging methods in pulse EPR - abstract: precise partial oxygen pressure (PO2) measurements can guide… (R44CA302113), from National Cancer Institute, on September 19, 2025.
On GovTribe
See O2M Technologies LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors